Primary Osteoporosis
7
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Community Smart Aging Model - Resistance Training
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
Vitamin D Status and Multi-Omics Profiles in Primary Osteoporosis
The Effects of Mindful Exercise on Back Pain in Older Patients With Primary Osteoporosis
The Study of Chinese Medicine for the Treatment of Primary Osteoporosis
Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women
Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis